valspodar: Clinical Trials

6 trials of valspodar, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed. 6 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 16Completed 6
Phase 21Completed 1

Follow valspodar: new trials by email Literature Review of valspodar trials Research Report on valspodar

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Liposomal Doxorubicin and PSC 833 in Treating Patients With AIDS-Related Kaposi's Sarcoma or Other Advanced Cancers
pegylated liposomal doxorubicin hydrochloride, PSC 833 - Sarcoma, Unspecified Adult Solid Tumor, Protocol Specific
Phase 1CompletedWashington University School of Medicine141998-03-012013-04-12
Combination Chemotherapy Plus PSC 833 Followed by Interleukin-2 in Treating Patients With Acute Myelogenous Leukemia
ara-C, Daunorubicin, Etoposide - Leukemia
Phase 1 / Phase 2CompletedNational Cancer Institute (NCI)4101997-02-012012-11-30
A Phase I Study of Continuous Intravenous Infusion of PSC 833 and Vinblastine in Patients With Metastatic Renal Cancer
PSC 833, vinblastine - Kidney Neoplasms, Neoplasm Metastasis
Phase 1CompletedNational Cancer Institute (NCI)461997-02-012008-03-04
Combination Chemotherapy Plus PSC-833 in Treating Children With Refractory or Relapsed Acute Leukemia
etoposide, mitoxantrone hydrochloride, valspodar - Leukemia
Phase 1CompletedNational Cancer Institute (NCI)31997-01-012013-02-01
A Phase I Study of Infusional Paclitaxel With the P-Glycoprotein Antagonist PSC 833
PSC 833, paclitaxel - Breast Cancer, Cancer
Phase 1CompletedNational Cancer Institute (NCI)521994-03-012008-03-04
A Phase I Study of Infusional Chemotherapy With the P-Glycoprotein Antagonist PSC 833
PSC 833 - Breast Cancer, Kidney Neoplasm
Phase 1CompletedNational Cancer Institute (NCI)801992-09-012008-03-04

Conditions studied

Breast Neoplasms (2)  ·  Kidney Neoplasms (2)  ·  Leukemia (2)  ·  Lymphoma (2)  ·  Neoplasm Metastasis (2)  ·  Ovarian Neoplasms (2)  ·  AIDS-related Kaposi sarcoma (1)  ·  Carcinoma, Renal Cell (1)  ·  Leukemia, Erythroblastic, Acute (1)  ·  Leukemia, Megakaryoblastic, Acute (1)  ·  Leukemia, Monocytic, Acute (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Leukemia, Myelomonocytic, Acute (1)  ·  Neoplasms (1)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)

Sponsors

National Cancer Institute (NCI) (5)  ·  Washington University School of Medicine (1)

Countries

United States (6)  ·  Australia (1)  ·  Canada (1)

Top investigators

Gary V.H. Dahl, MD (1)  ·  Jonathan E. Kolitz, MD (1)  ·  Paula M. Fracasso, MD, PhD (1)

Results publications

PMID 11331327, PMID 11585760, PMID 12750167, PMID 15514371, PMID 16275934, PMID 16670265, PMID 20209646

NIH funding

U10CA031946 (1)